161 studies found for:    BRCA1
Show Display Options
Rank Status Study
1 Unknown  The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers
Condition: Breast Cancer
Intervention: Dietary Supplement: Diindolylmethane (DIM)
2 Unknown  Impact of Testing Positive for the BRCA1 or BRCA2 Mutation in Young Women Who Are BRCA1 or BRCA2 Mutation Carriers
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Sexuality and Reproductive Issues
Interventions: Behavioral: telephone-based intervention;   Other: questionnaire administration;   Procedure: psychosocial assessment and care
3 Recruiting Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Breast Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2)
Intervention: Drug: letrozole
4 Withdrawn Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Breast Cancer
Interventions: Genetic: DNA analysis;   Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Procedure: evaluation of cancer risk factors
5 Unknown  Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Breast Cancer
Interventions: Genetic: DNA analysis;   Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Procedure: evaluation of cancer risk factors
6 Recruiting Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children
Conditions: Breast Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2)
Interventions: Other: counseling intervention;   Other: educational intervention;   Other: survey administration;   Behavioral: psychosocial assessment and care;   Behavioral: supportive care
7 Completed BRCA1 Haploinsufficiency and Gene Expression
Condition: BRCA1 Mutations
Intervention:
8 Completed Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients
Conditions: BRCA1 Mutation;   Metastatic Breast Cancer
Intervention: Drug: Cisplatin
9 Recruiting The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
Condition: Prostate Cancer in BRCA1 and BRCA2 Carriers
Interventions: Behavioral: PSA test;   Procedure: Prostate Biopsy
10 Recruiting Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland
Conditions: BRCA1 Mutation;   Breast Cancer Invasive Nos
Intervention: Drug: Neoadjuvant Cisplatin Chemotherapy
11 Recruiting COsegregation of VARiants in the BRCA1/2 Genes
Conditions: Genes, BRCA1;   Genes, BRCA2;   Ovarian Neoplasms;   Breast Neoplasms
Intervention: Genetic: salivary kit
12 Recruiting Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer
Condition: BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype
Intervention: Drug: Trabectedin
13 Recruiting Validation of a Mouse Model of Pancreatic Carcinogenesis
Condition: Pancreatic Cancer
Intervention:
14 Unknown  Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Gemcitabine, Docetaxel, CPT-11,Cisplatin;   Drug: gemcitabine/cisplatin
15 Active, not recruiting A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
Condition: Breast Cancer
Intervention:
16 Active, not recruiting Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
Conditions: Ovarian;   Breast;   Prostate;   Pancreatic;   Advanced Tumours
Intervention: Drug: olaparib
17 Not yet recruiting BRCA1/2 and Effect of Mifepristone on the Breast
Condition: Women With Mutations in the Breast Cancer Susceptibility Genes BRCA-1 and -2.
Intervention: Drug: Mifepristone
18 Active, not recruiting ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer
Conditions: Breast Cancer;   Metastatic Breast Cancer;   BRCA1 or BRCA2 Associated Breast Cancer
Interventions: Drug: ABT-888;   Drug: temozolomide
19 Recruiting Triple Negative Breast Cancer: Study of Molecular and Genetic Factors
Condition: Breast Cancer
Intervention: Genetic: BRCA1 BRCA2 PTEN PALB2 mutation
20 Not yet recruiting Transformation Potential of E2 Exposed Breast Cancer Susceptibility Gene Mutation Heterozygous Epithelial Breast Cells
Conditions: BRCA1 Gene Mutation;   BRCA2 Gene Mutation
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years